Hantz Financial Services Inc. Raises Stock Position in Envista Holdings Co. (NYSE:NVST)

Hantz Financial Services Inc. increased its stake in Envista Holdings Co. (NYSE:NVST - Free Report) by 146.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 110,489 shares of the company's stock after acquiring an additional 65,679 shares during the period. Hantz Financial Services Inc. owned approximately 0.06% of Envista worth $2,131,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of the stock. Mirae Asset Global Investments Co. Ltd. bought a new stake in shares of Envista during the 3rd quarter worth approximately $31,000. GAMMA Investing LLC raised its stake in shares of Envista by 69.8% during the third quarter. GAMMA Investing LLC now owns 1,766 shares of the company's stock valued at $35,000 after acquiring an additional 726 shares in the last quarter. Huntington National Bank boosted its holdings in shares of Envista by 97.8% in the third quarter. Huntington National Bank now owns 1,919 shares of the company's stock valued at $38,000 after purchasing an additional 949 shares during the period. Blue Trust Inc. grew its stake in Envista by 69.7% in the third quarter. Blue Trust Inc. now owns 1,957 shares of the company's stock worth $39,000 after purchasing an additional 804 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC increased its holdings in Envista by 50.8% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 2,161 shares of the company's stock worth $43,000 after purchasing an additional 728 shares during the period.

Envista Stock Performance

NVST traded down $0.48 on Monday, reaching $20.04. 2,326,657 shares of the stock were exchanged, compared to its average volume of 1,877,645. The company's 50-day moving average price is $20.08 and its 200 day moving average price is $19.04. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.08 and a quick ratio of 1.77. The firm has a market capitalization of $3.45 billion, a PE ratio of -2.58, a PEG ratio of 1.82 and a beta of 1.34. Envista Holdings Co. has a fifty-two week low of $15.15 and a fifty-two week high of $24.79.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on NVST shares. Wells Fargo & Company began coverage on Envista in a research report on Tuesday, October 8th. They set an "equal weight" rating and a $20.00 price target on the stock. Leerink Partnrs raised shares of Envista from a "strong sell" rating to a "hold" rating in a research report on Thursday, October 31st. Robert W. Baird upped their price target on shares of Envista from $17.00 to $22.00 and gave the stock a "neutral" rating in a research report on Thursday, October 31st. Needham & Company LLC reissued a "hold" rating on shares of Envista in a report on Thursday, October 31st. Finally, Leerink Partners raised Envista from an "underperform" rating to a "market perform" rating and increased their target price for the company from $16.00 to $23.00 in a research report on Thursday, October 31st. Two analysts have rated the stock with a sell rating, ten have given a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of $20.21.

Envista Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.